BioTelemetry (BEAT) Tops Q2 EPS by 8c

July 30, 2019 4:11 PM

BioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.53, $0.08 better than the analyst estimate of $0.45. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found